Latest Commercialisation News

Page 13 of 239
Firebrick Pharma has secured Philippine marketing approval for Nasodine Nasal Spray as an over-the-counter antiseptic, opening a potential launch in the 116 million-person market from early 2027. The approval remains subject to post-approval documentation and future revalidation.
Victor Sage
Victor Sage
16 Oct 2026
Adveritas has secured a $2 million placement at a 42.9% premium to its last close, with the proceeds earmarked for product development, marketing and working capital. The funding comes as the company pushes beyond sports betting and gaming while managing delayed Brazilian customer payments.
Sophie Babbage
Sophie Babbage
15 Oct 2026
Centuria Industrial REIT has agreed almost 25,000 square metres of leases at a 31% year-to-date re-leasing spread, while selling a vacant Queensland asset for $34.25 million at book value. The industrial landlord reaffirmed FY27 earnings and distribution guidance as it advances longer-term data centre and renewable energy opportunities.
Eva Park
Eva Park
15 Oct 2026
BLS Pharmaceuticals has opened FY27 with record quarterly revenue, positive operating cash flow and reaffirmed full-year guidance. The report contains conflicting Q1 revenue figures of $26.7 million and $27.5 million, while its Scotland expansion remains subject to regulatory approval.
Victor Sage
Victor Sage
15 Oct 2026
Integrated Research’s FY26 annual report confirms a sharp earnings deterioration, with revenue down 16% and net profit collapsing to A$1.2 million. A stronger cash balance and new AI products offer financial resilience, but FY27 now hinges on turning product launches into commercial adoption.
Sophie Babbage
Sophie Babbage
14 Oct 2026
Biotron has appointed Glenn Gilbert as chief executive and executive director, bringing more than two decades of pharmaceutical, medical device and diagnostics experience to the company’s SedRx and antiviral programs. His package combines a $250,000 salary with up to 100 million performance-based options and $230,000 in milestone-linked cash bonuses.
Victor Sage
Victor Sage
14 Oct 2026
Condor Energy has secured formal qualification from Peru’s state oil and gas agency, allowing it to negotiate a proposed exploration and exploitation licence for offshore Block Z-72. The milestone moves the project forward, but it is not a final licence award.
Victor Sage
Victor Sage
14 Oct 2026
PARKD has secured an exclusive three-year partnership with ASX-listed Symal across Victoria and South Australia, alongside an A$800,000 placement priced at a premium. The deal expands PARKD’s east coast delivery network, although future projects and revenue remain uncommitted.
Victor Sage
Victor Sage
13 Oct 2026
Orthocell says Remplir was placed successfully in five complex robotic prostatectomy cases, with no device-related complications reported over approximately 12 months. The preliminary results will guide a larger prospective trial ahead of a planned US expansion for the nerve repair product.
Ada Torres
Ada Torres
13 Oct 2026
Vection Technologies has secured a multi-year framework agreement with Italian telecommunications provider Retelit Digital Service, which has committed to generate at least approximately A$19.5 million in revenue for the company by June 2030. The deal expands Vection’s route into enterprise customers across Italy and Europe, although margins and payment terms remain undisclosed.
Sophie Babbage
Sophie Babbage
13 Oct 2026
FortifAI says independent verification found its NOL8 AI Data Plane delivered up to 118 times more data per infrastructure dollar than Google RE2 at the highest workload tested. The result supports NOL8’s commercialisation push, while also triggering the vesting of 52,516,667 Class C Performance Rights.
Sophie Babbage
Sophie Babbage
12 Oct 2026
Li-S Energy has signed an agreement to evaluate its Australian-made lithium-sulfur batteries in Safesky Systems' tactical drone platforms. The collaboration opens a potential defence supply pathway, but commercial orders remain dependent on testing and customer procurement decisions.
Victor Sage
Victor Sage
9 Oct 2026

Browse the archive

Full archive